A group of investors who purchased a Carlisle life settlement product through HDFC Bank's Dubai operations is reportedly preparing to approach the Prime Minister's Office (PMO) over allegations of mis-selling, significant financial losses and prolonged difficulties in redeeming their investments.

According to The Economic Times, the investor group comprises more than 75 investors, representing over $13.5 million in principal investment in the Carlisle Luxembourg Life Fund. The investors are also considering approaching the Reserve Bank of India (RBI) and the Central Bank of Bahrain, while some have reportedly already complained to the Dubai Financial Services Authority (DFSA).It is important to note that these are allegations made by investors and have not been established as wrongdoing by HDFC Bank in this matter.

What Is the Carlisle-HDFC Bank Dispute?

The dispute relates to a life settlement product linked to Carlisle's Luxembourg Life Fund, which some investors purchased through HDFC Bank's Dubai operations.

Investors allege that the product was presented as a capital-protection and insurance-linked investment, with one investor claiming that historical returns of around 12–19% annually were highlighted during the sales process.

The investors further allege that leverage offered alongside the investment substantially increased their exposure. According to an investor cited by The Economic Times, HDFC Bank allegedly offered leverage of around three to five times the amount of deposits blocked with the bank for investment in these products.

The investors claim that this structure increased their losses during the Covid-19 market crash.

Why Are Investors Approaching the PMO?

The planned approach to the PMO represents an escalation after what investors describe as years of difficulty with the investment.

The group reportedly intends to raise concerns around:

• Client suitability
• Product disclosures
• Leverage offered alongside investments
• Investor losses
• Liquidity and redemption difficulties
• The manner in which the product was marketed

The investors are seeking intervention and referral of the matter to appropriate regulatory and investigative authorities.

What Are the Investors Alleging?

The allegations broadly centre around the risk profile and presentation of the product.

Investors claim that the product was presented as relatively protected or insurance-linked, while the leverage associated with the investment increased their effective exposure.

They also allege that they have faced years-long difficulties in redeeming their investments, resulting in concerns around liquidity.

However, the precise contractual terms, disclosures provided to individual investors and suitability assessments would need to be examined to determine the merits of these claims.

What Is a Life Settlement Investment?

A life settlement generally involves the purchase of an existing life-insurance policy from its policyholder, with the purchaser subsequently receiving the policy benefits when the insured event occurs, subject to the structure of the investment.

Such investments can have risks that differ substantially from conventional fixed-income or equity investments.

Potential risks can include:

• Longevity risk
• Liquidity risk
• Valuation risk
• Financing or leverage risk
• Insurance-related risks
• Counterparty and structural risks

Therefore, understanding the product structure and associated risks is particularly important before investing.

Why Is Leverage an Important Issue?

Leverage can amplify both gains and losses.

For example, if an investor has ₹1 crore of their own capital and uses additional borrowed funds to create a ₹4 crore investment exposure, a decline in the underlying investment can result in losses that are significantly larger relative to the investor's original capital.

This is why investors are raising questions about the leverage allegedly associated with the Carlisle investment.

The investor group has specifically cited concerns about how leverage affected their exposure and losses during the Covid-era market disruption.

What About the HDFC Bank Dubai Operations?

The allegations relate specifically to HDFC Bank's Dubai operations, rather than necessarily the bank's entire business.

The matter is also separate from another regulatory episode involving HDFC Bank's DIFC branch.

In 2025, the Dubai Financial Services Authority (DFSA) imposed restrictions on HDFC Bank's DIFC branch following concerns relating to client onboarding practices and the alleged mis-selling of high-risk Credit Suisse AT1 bonds to retail customers. HDFC Bank's own disclosures state that the branch was restricted from offering certain financial services to new customers while continuing to service existing clients.

The current Carlisle-related allegations are therefore attracting additional attention because of this regulatory background.

Which Regulatory Authorities Could Be Involved?

The investors are reportedly considering approaching multiple authorities.

Prime Minister's Office

The investor group plans to submit its representation to the PMO and request that the matter be referred to appropriate authorities.

Reserve Bank of India

The group reportedly plans to approach the RBI regarding its concerns.

Central Bank of Bahrain

Investors also intend to file a complaint with the Central Bank of Bahrain, according to reports.

Dubai Financial Services Authority

Some investors have reportedly already approached the DFSA independently.

The DFSA is the financial-services regulator for firms operating within the Dubai International Financial Centre (DIFC).

What Has HDFC Bank Said?

The latest reports focus primarily on the investors' allegations and planned regulatory action. The bank's response to the specific Carlisle allegations will be important as the matter develops.

According to the reported timeline, the investor group has written to HDFC Bank and given the bank until August 31, 2026, to respond. The group has indicated that it may pursue legal action if it does not receive a satisfactory response.

Investors and market participants should therefore watch for further statements from HDFC Bank and any response from regulators.

Why Is This Important for Investors?

The case highlights several important principles around investment products and wealth management.

1. Understand the Product Before Investing

An investment described as insurance-linked or capital-protection oriented can still carry significant risks depending on its structure.

2. Leverage Can Change the Risk Profile

Borrowing to invest can magnify losses. Investors should understand the maximum potential downside before accepting leverage.

3. Liquidity Matters

An investment may generate attractive projected returns but still be unsuitable if investors cannot easily redeem their money when required.

4. Past Returns Do Not Guarantee Future Returns

Historical returns, even when accurately presented, do not guarantee future performance.

5. Suitability Is Critical

Complex investment products need to be assessed against an investor's financial objectives, risk tolerance, liquidity requirements and investment experience.

What Happens Next?

The immediate developments to watch include:

• The response from HDFC Bank before or around August 31
• Whether investors formally approach the PMO
• Any complaint filed with the RBI
• Any action by the Central Bank of Bahrain
• Further proceedings before the DFSA
• Potential legal action by investors
• Any official response from HDFC Bank regarding the allegations

The outcome will depend on the evidence, contractual documents, regulatory reviews and responses from the institutions involved.

Impact on HDFC Bank

At this stage, it would be premature to conclude that the Carlisle allegations will have a material financial impact on HDFC Bank.

The matter relates to the bank's Dubai operations and involves allegations that still need to be examined by the relevant authorities.

However, from a broader perspective, the issue highlights the importance of client suitability, product governance, risk disclosure and wealth-management practices, particularly when dealing with complex investment products.

For investors tracking HDFC Bank, the key things to monitor will be any official regulatory action, material disclosures from the bank and developments that could have a financial or reputational impact.

Conclusion

The proposed approach to the PMO by Carlisle investors over alleged HDFC Bank mis-selling has brought renewed attention to a dispute involving a life settlement investment sold through HDFC Bank's Dubai operations.

More than 75 investors, representing over $13.5 million in principal investment, are reportedly consolidating their complaints and considering regulatory and legal avenues. Their concerns include alleged mis-selling, product suitability, leverage, disclosures, investment losses and prolonged redemption difficulties.

For investors, the case serves as a reminder that understanding the structure, risks, liquidity conditions and leverage associated with an investment is essential, particularly when dealing with complex financial products.

The allegations remain subject to investigation and regulatory or legal review. The next significant developments will likely depend on HDFC Bank's response and whether investors formally approach the PMO and other regulators.

FAQs

1. What is the Carlisle-HDFC Bank mis-selling case?

The case concerns allegations by investors who purchased a Carlisle life settlement product through HDFC Bank's Dubai operations. The investors allege mis-selling, losses and difficulties in redeeming their investments.

2. How many investors are involved?

According to The Economic Times, the investor group comprises more than 75 investors with over $13.5 million in principal investment in the Carlisle Luxembourg Life Fund.

3. Why are Carlisle investors approaching the PMO?

The investors reportedly want to escalate their complaints concerning alleged client-suitability lapses, leverage, disclosures, losses and liquidity issues and seek referral of the matter to appropriate authorities.

4. What is the main allegation against HDFC Bank?

Investors allege that the Carlisle product was marketed as a capital-protection or insurance-linked investment and that leverage offered alongside it increased their exposure and losses. These allegations have not been established as wrongdoing by HDFC Bank.

5. What regulators could examine the matter?

Investors have indicated plans to approach the RBI and Central Bank of Bahrain, while some have reportedly already complained to the DFSA.

6. What is the role of leverage in the dispute?

Investors allege that leverage of around three to five times the blocked deposit amount was offered, potentially increasing their effective investment exposure and magnifying losses during market stress.

7. Has HDFC Bank been found guilty of mis-selling the Carlisle product?

The allegations reported in the media do not by themselves establish wrongdoing. Any determination would depend on the relevant regulatory or legal proceedings and the evidence examined.

8. What should investors learn from this case?

Investors should carefully evaluate product structure, risk, leverage, liquidity, fees, disclosures and suitability before investing in complex financial products.

Disclaimer: This article is based on publicly reported allegations and should not be interpreted as a finding of wrongdoing. The matter remains subject to responses, regulatory review and/or legal proceedings. This article is for educational and informational purposes only and should not be considered investment or legal advice.